These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12730878)

  • 1. Galectin-1 suppresses experimental colitis in mice.
    Santucci L; Fiorucci S; Rubinstein N; Mencarelli A; Palazzetti B; Federici B; Rabinovich GA; Morelli A
    Gastroenterology; 2003 May; 124(5):1381-94. PubMed ID: 12730878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis.
    Santucci L; Wallace J; Mencarelli A; Farneti S; Morelli A; Fiorucci S
    Gastroenterology; 2005 May; 128(5):1243-57. PubMed ID: 15887108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
    Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
    J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.
    Fiorucci S; Mencarelli A; Palazzetti B; Distrutti E; Vergnolle N; Hollenberg MD; Wallace JL; Morelli A; Cirino G
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13936-41. PubMed ID: 11717450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.
    Fuss IJ; Marth T; Neurath MF; Pearlstein GR; Jain A; Strober W
    Gastroenterology; 1999 Nov; 117(5):1078-88. PubMed ID: 10535870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
    Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
    J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis.
    Fiorucci S; Distrutti E; Mencarelli A; Barbanti M; Palazzini E; Morelli A
    Digestion; 2002; 66(4):246-56. PubMed ID: 12592101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production.
    Carvalho AT; Souza H; Carneiro AJ; Castelo-Branco M; Madi K; Schanaider A; Silv F; Pereira Junior FA; Pereira MG; Tortori C; Dines I; Carvalho J; Rocha E; Elia C
    World J Gastroenterol; 2007 Apr; 13(15):2166-73. PubMed ID: 17465495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
    Boirivant M; Fuss IJ; Ferroni L; De Pascale M; Strober W
    J Immunol; 2001 Mar; 166(5):3522-32. PubMed ID: 11207312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.
    Palmen MJ; Wijburg OL; Kunst IH; Kroes H; van Rees EP
    Clin Exp Immunol; 1998 May; 112(2):216-25. PubMed ID: 9649183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
    Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
    J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.
    Pfister K; Wittig BM; Jüngling B; Ecker KW; Barth S; Huhn M; Sasse S; Engert A; Mueller-Molaian I; Diehl V; Zeitz M; Stallmach A
    Int J Colorectal Dis; 2002 Mar; 17(2):77-84. PubMed ID: 12014425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase-1 suppresses experimental colitis via the inhibition of IFN-γ production from CD4 T cells.
    Yamashita J; Iwamura C; Ito T; Narita M; Hara Y; Sasaki T; Masuda D; Takahashi M; Tsuchiya M; Hada K; Ishikawa M; Matsuo T; Ohno Y; Tanaka H; Maruyama H; Ogawa Y; Nakayama T
    J Immunol; 2013 Jul; 191(2):949-60. PubMed ID: 23772025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E₂ receptor subtype 4 agonist.
    Okamoto T; Uemoto S; Tabata Y
    J Pharmacol Exp Ther; 2012 May; 341(2):340-9. PubMed ID: 22300734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
    Stallmach A; Marth T; Weiss B; Wittig BM; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
    Gut; 2004 Mar; 53(3):339-45. PubMed ID: 14960512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.